0A4F4F9BD490A749D5437F821CF06DF1
EU Clinical Trials Register: FAQs
https://www.clinicaltrialsregister.eu/doc/EU_CTR_FAQ.pdf
http://leaux.net/URLS/ConvertAPI Text Files/150764384156A90932F0BCBDF0B74CAB.en.txt
Examining the file media/Synopses/150764384156A90932F0BCBDF0B74CAB.html:
This file was generated: 2020-07-15 06:43:33
| Indicators in focus are typically shown highlighted in yellow; |
Peer Indicators (that share the same Vulnerability association) are shown highlighted in pink; |
"Outside" Indicators (those that do NOT share the same Vulnerability association) are shown highlighted in green; |
Trigger Words/Phrases are shown highlighted in gray. |
Link to Orphaned Trigger Words (Appendix (Indicator List, Indicator Peers, Trigger Words, Type/Vulnerability/Indicator Overlay)
Applicable Type / Vulnerability / Indicator Overlay for this Input
Social / Access to Social Goods
Searching for indicator access:
(return to top)
p.(None): or the European Economic Area.
p.(None): • The description of any paediatric clinical trial with investigator sites in the European Union.
p.(None): • The description of any paediatric clinical trial that is marketing authorisation holder- sponsored and involves
p.(None): the use in the paediatric population of a medicinal product covered by an EU marketing authorisation (Article 46 of
p.(None): Regulation (EC) No 1901/2006), including those where the investigator sites are outside the European Union.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 2/7
p.(None):
p.(None): • The description of any trials which form part of an agreed paediatric investigation plan (PIP) including those
p.(None): where the investigator sites are outside the European Union.
p.(None): • Summaries of results of the clinical trials mentioned above (if results have been posted by the sponsor or
p.(None): marketing authorisation holder).
p.(None): • Summaries of results (with a reduced set of data fields) of paediatric trials that were completed by 26 January
p.(None): 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation (EC) No 1901/2006)
p.(None): [These trials are presented in a dedicated tab in the user interface.]
p.(None): The EU Clinical Trials Register website does not:
p.(None):
p.(None): • Provide information on non-interventional clinical trials of medicines (observational studies on authorised
p.(None): medicines).
p.(None): • Provide access to the authorisation document from the national medicine regulatory authority or the opinion
p.(None): document from the relevant ethics committee.
p.(None): • Provide information on clinical trials for surgical procedures, medical devices or psychotherapeutic procedures.
p.(None): • Manage the process for joining any clinical trial published on the website.
p.(None):
p.(None): • Provide navigation and web content in languages other than English.
p.(None): *Information on non-interventional post authorisation safety studies can be found on the electronic ENCePP register of
p.(None): studies which provides a publicly accessible resource for the registration of pharmacoepidemiological and
p.(None): pharmacovigilance studies.
p.(None): http://www.encepp.eu/encepp/studiesDatabase.jsp
p.(None):
p.(None): Q.4. What information is available?
p.(None): A. Information on the design of each clinical trial, its sponsor(s), the investigational medicinal product(s) and
p.(None): therapeutic area(s) involved and its trial status (authorised, ongoing, complete, etc.) is available. Users can search
p.(None): all available data using the free text search and the advanced search filters..
p.(None): • Clinical trials in the register are those which have been authorised by the national medicine regulatory
p.(None): authority and have a positive opinion of the ethics committee for clinical trials in the Member State where they have
...
Searching for indicator access to information:
(return to top)
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): 7 March 2014 EMA/199793/2011
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): Questions and answers relating to practical and technical aspects of the EU Clinical Trials Register
p.(None):
p.(None):
p.(None): IMPORTANT: Refer to the How to Search EU Clinical Trials Register guide (under ‘About here for more information’ on the
p.(None): EU CTR Search page) for detailed guidance on using the search functionality.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom
p.(None): Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20
p.(None): E-mail info@ema.europa.eu Website www.ema.europa.eu
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): An agency of the European Union
p.(None):
p.(None): © European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged.
p.(None):
p.(None):
p.(None): Q.1. What is the EU Clinical Trials Register?
p.(None): A. The EU Clinical Trials Register is part of EudraPharm. EudraPharm is the community database of authorised medicinal
p.(None): products. The website provides public access to information extracted from the EU clinical trials database, EudraCT.
p.(None): The EU Clinical Trials Register contains information on clinical trials with investigator sites in the EEA. Clinical
p.(None): trials where the investigator sites are outside the EEA are only included if they are marketing authorisation
p.(None): holder-sponsored and involve the use in the paediatric population of a medicinal product covered by an EU marketing
p.(None): authorisation (Article 46 of Regulation (EC) No 1901/2006), or if they form part of an agreed PIP (Paediatric
p.(None): Investigation Plan). The register offers users the ability to search for information on any paediatric clinical trial,
p.(None): and any Phase II-IV adult clinical trial recorded in EudraCT.
p.(None): In addition to the above trials, the register also provides summary information about any paediatric trials that were
p.(None): completed by 26 January 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation
p.(None): (EC) No 1901/2006). These trials are presented in a dedicated tab in the user interface.
p.(None):
p.(None): Q.2. Why has the EU Clinical Trials Register been launched?
p.(None): A. The EU Clinical Trials Register website provides the public with information held in the EU clinical trials
p.(None): database, EudraCT. EudraCT is used by national competent authorities to support supervision of clinical trials and was
p.(None): established as a confidential database, in accordance with article 11 of Directive 2001/20/EC. EU pharmaceutical
p.(None): legislation requires the European Medicines Agency (EMA), which maintains the EudraCT database on behalf of EU member
p.(None): states to provide information held in EudraCT to the public. This is described in article 57 of Regulation (EC) No
p.(None): 726/2004 and article 41 of the Paediatric Regulation (EC) No 1901/2006. Together, they established that data on
...
Social / Marital Status
Searching for indicator single:
(return to top)
p.(None): search your browser’s help for information on its particular implementation.
p.(None): The EU Clinical Trials Register provides customised RSS feeds for any search you might make regularly on the website.
p.(None): For example, if you are interested in clinical trials concerning ‘bowel cancer’, you can tailor your search within the
p.(None): EU Clinical Trials Register search page and simply subscribe to the RSS feed for your search by clicking the RSS link:
p.(None): Once subscribed, you will be able to see when your search returns additional results via your RSS reader. (Note that
p.(None): this feature is not available in Internet Explorer 6.)
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 5/7
p.(None):
p.(None): Q.13 When I select United Kingdom with the status 'Ongoing', why do the search results return clinical trials with
p.(None): the status for United Kingdom 'Completed'?A: Such a search returns a list of clinical trials for which the values ‘GB’
p.(None): and ‘Ongoing’ are present. It should be noted that this does not mean that the status 'Ongoing' is necessarily
p.(None): associated with the country ‘GB’, but rather that it is associated with the clinical trial itself which may have
p.(None): multiple trial statuses across all participating countries.
p.(None): Q.14 Why is for example the sum of returned trial records of a search for United Kingdom phase II ongoing trials
p.(None): commenced in 2011 and that of United Kingdom phase II completed trials commenced in 2011 not the same as the sum of
p.(None): returned trial records of United Kingdom phase II ongoing and completed trials commenced in 2011?
p.(None): A: Both trial statuses of ‘Completed’ and ‘Ongoing’ may be present for a single clinical trial, because trials
p.(None): frequently take place in multiple countries. For example, a clinical trial taking place in the United Kingdom and
p.(None): France might, at some point in time, have a trial status of ‘Completed’ in France and ‘Ongoing’ in the United Kingdom.
p.(None): Such clinical trials therefore belong to the intersection between the two sets of search results, since they fulfil
p.(None): search criteria (i.e. UK Phase II ongoing trials commenced in 2011 and UK Phase II completed trials commenced in 2011)
p.(None): as the following Venn diagram illustrates:
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 6/7
p.(None):
p.(None): Simply adding up the numbers of set 1 (UK Phase II ‘Ongoing’ 2011 (313)) and set 2 (UK Phase II ‘Completed’ 2011 (48))
p.(None): would result in double counting 30 clinical trials in the intersection, so these must be subtracted to reach an
p.(None): accurate total.
p.(None): Q.15 What should I do if my question is not answered here?
p.(None): A: If your question regarding the EU Clinical Trials Register is not answered here, or in the How to Search EU Clinical
p.(None): Trials Register guide, please send your question to euctr@ema.europa.eu.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
...
Social / Trade Union Membership
Searching for indicator union:
(return to top)
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): 7 March 2014 EMA/199793/2011
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): Questions and answers relating to practical and technical aspects of the EU Clinical Trials Register
p.(None):
p.(None):
p.(None): IMPORTANT: Refer to the How to Search EU Clinical Trials Register guide (under ‘About here for more information’ on the
p.(None): EU CTR Search page) for detailed guidance on using the search functionality.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom
p.(None): Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20
p.(None): E-mail info@ema.europa.eu Website www.ema.europa.eu
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): An agency of the European Union
p.(None):
p.(None): © European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged.
p.(None):
p.(None):
p.(None): Q.1. What is the EU Clinical Trials Register?
p.(None): A. The EU Clinical Trials Register is part of EudraPharm. EudraPharm is the community database of authorised medicinal
p.(None): products. The website provides public access to information extracted from the EU clinical trials database, EudraCT.
p.(None): The EU Clinical Trials Register contains information on clinical trials with investigator sites in the EEA. Clinical
p.(None): trials where the investigator sites are outside the EEA are only included if they are marketing authorisation
p.(None): holder-sponsored and involve the use in the paediatric population of a medicinal product covered by an EU marketing
p.(None): authorisation (Article 46 of Regulation (EC) No 1901/2006), or if they form part of an agreed PIP (Paediatric
p.(None): Investigation Plan). The register offers users the ability to search for information on any paediatric clinical trial,
p.(None): and any Phase II-IV adult clinical trial recorded in EudraCT.
p.(None): In addition to the above trials, the register also provides summary information about any paediatric trials that were
p.(None): completed by 26 January 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation
p.(None): (EC) No 1901/2006). These trials are presented in a dedicated tab in the user interface.
p.(None):
p.(None): Q.2. Why has the EU Clinical Trials Register been launched?
p.(None): A. The EU Clinical Trials Register website provides the public with information held in the EU clinical trials
p.(None): database, EudraCT. EudraCT is used by national competent authorities to support supervision of clinical trials and was
p.(None): established as a confidential database, in accordance with article 11 of Directive 2001/20/EC. EU pharmaceutical
p.(None): legislation requires the European Medicines Agency (EMA), which maintains the EudraCT database on behalf of EU member
p.(None): states to provide information held in EudraCT to the public. This is described in article 57 of Regulation (EC) No
p.(None): 726/2004 and article 41 of the Paediatric Regulation (EC) No 1901/2006. Together, they established that data on
p.(None): clinical trials conducted in adults and in paediatric populations be made public. The EU Clinical Trials Register
p.(None): website puts these requirements into practice.
p.(None): Q.3. What information can I find in the EU Clinical Trials Register?
p.(None): A. The EU Clinical Trials Register website has:
p.(None):
p.(None): • The description of any phase II-IV adult clinical trial where the investigator sites are in the European Union
p.(None): or the European Economic Area.
p.(None): • The description of any paediatric clinical trial with investigator sites in the European Union.
p.(None): • The description of any paediatric clinical trial that is marketing authorisation holder- sponsored and involves
p.(None): the use in the paediatric population of a medicinal product covered by an EU marketing authorisation (Article 46 of
p.(None): Regulation (EC) No 1901/2006), including those where the investigator sites are outside the European Union.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 2/7
p.(None):
p.(None): • The description of any trials which form part of an agreed paediatric investigation plan (PIP) including those
p.(None): where the investigator sites are outside the European Union.
p.(None): • Summaries of results of the clinical trials mentioned above (if results have been posted by the sponsor or
p.(None): marketing authorisation holder).
p.(None): • Summaries of results (with a reduced set of data fields) of paediatric trials that were completed by 26 January
p.(None): 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation (EC) No 1901/2006)
p.(None): [These trials are presented in a dedicated tab in the user interface.]
p.(None): The EU Clinical Trials Register website does not:
p.(None):
p.(None): • Provide information on non-interventional clinical trials of medicines (observational studies on authorised
p.(None): medicines).
p.(None): • Provide access to the authorisation document from the national medicine regulatory authority or the opinion
p.(None): document from the relevant ethics committee.
p.(None): • Provide information on clinical trials for surgical procedures, medical devices or psychotherapeutic procedures.
p.(None): • Manage the process for joining any clinical trial published on the website.
p.(None):
p.(None): • Provide navigation and web content in languages other than English.
p.(None): *Information on non-interventional post authorisation safety studies can be found on the electronic ENCePP register of
p.(None): studies which provides a publicly accessible resource for the registration of pharmacoepidemiological and
p.(None): pharmacovigilance studies.
p.(None): http://www.encepp.eu/encepp/studiesDatabase.jsp
p.(None):
p.(None): Q.4. What information is available?
...
Social / philosophical differences/differences of opinion
Searching for indicator opinion:
(return to top)
p.(None): • The description of any paediatric clinical trial that is marketing authorisation holder- sponsored and involves
p.(None): the use in the paediatric population of a medicinal product covered by an EU marketing authorisation (Article 46 of
p.(None): Regulation (EC) No 1901/2006), including those where the investigator sites are outside the European Union.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 2/7
p.(None):
p.(None): • The description of any trials which form part of an agreed paediatric investigation plan (PIP) including those
p.(None): where the investigator sites are outside the European Union.
p.(None): • Summaries of results of the clinical trials mentioned above (if results have been posted by the sponsor or
p.(None): marketing authorisation holder).
p.(None): • Summaries of results (with a reduced set of data fields) of paediatric trials that were completed by 26 January
p.(None): 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation (EC) No 1901/2006)
p.(None): [These trials are presented in a dedicated tab in the user interface.]
p.(None): The EU Clinical Trials Register website does not:
p.(None):
p.(None): • Provide information on non-interventional clinical trials of medicines (observational studies on authorised
p.(None): medicines).
p.(None): • Provide access to the authorisation document from the national medicine regulatory authority or the opinion
p.(None): document from the relevant ethics committee.
p.(None): • Provide information on clinical trials for surgical procedures, medical devices or psychotherapeutic procedures.
p.(None): • Manage the process for joining any clinical trial published on the website.
p.(None):
p.(None): • Provide navigation and web content in languages other than English.
p.(None): *Information on non-interventional post authorisation safety studies can be found on the electronic ENCePP register of
p.(None): studies which provides a publicly accessible resource for the registration of pharmacoepidemiological and
p.(None): pharmacovigilance studies.
p.(None): http://www.encepp.eu/encepp/studiesDatabase.jsp
p.(None):
p.(None): Q.4. What information is available?
p.(None): A. Information on the design of each clinical trial, its sponsor(s), the investigational medicinal product(s) and
p.(None): therapeutic area(s) involved and its trial status (authorised, ongoing, complete, etc.) is available. Users can search
p.(None): all available data using the free text search and the advanced search filters..
p.(None): • Clinical trials in the register are those which have been authorised by the national medicine regulatory
p.(None): authority and have a positive opinion of the ethics committee for clinical trials in the Member State where they have
p.(None): been run. Additionally, clinical trials including the paediatric population that have received a negative ethics
p.(None): committee opinion are also made public.
p.(None): • Phase 1 clinical trials in adults are not being made public unless they form part of an agreed Paediatric
p.(None): Investigation Plan (PIP). These criteria are those established by the guidelines published by the European Commission.
p.(None): Q.5. How do I find the EU Clinical Trials Register?
p.(None): A. The EU Clinical Trials Register is part of EudraPharm and can be accessed from the EudraPharm homepage
p.(None): The homepage of the EU Clinical Trial Register is: http://www.clinicaltrialsregister.eu
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 3/7
p.(None):
p.(None): Q.6. Who provides the information?
p.(None): A. Protocol information on any clinical trial conducted in the EU Member States is provided, in electronic format, to
p.(None): the national medicine regulatory authorities by the trial sponsor as part of the sponsor’s application for
p.(None): authorisation to conduct a trial. It is entered into the database by the national competent authority which adds the
p.(None): authorisation, the ethics committee opinion, and later completes the end-of-trial information.
p.(None): The information on third-country clinical trials is supplied by the third country data providers (i.e.
p.(None): Paediatric-Investigation-Plan (PIP) addressees or Article 46 data providers) who enter the information directly to the
p.(None): system.
p.(None): Result related information is entered by sponsors, marketing authorisation holders and PIP addressees directly to the
p.(None): system.
p.(None): Q.7 Data displayed for some clinical trials is incomplete. How will data quality improve?
p.(None): A. National competent authorities and the Agency are working to develop, where possible, a more complete data set for
p.(None): historical trials (May 2004-March 2011) entered in the EudraCT database. Furthermore, it aims to improve the quality of
p.(None): the new records through enhanced automated checking, quality control and through the increased use of standardised
p.(None): data.
p.(None): Data quality and historical information:
p.(None):
p.(None): Information on clinical trials entered into the database between May 2004 and March 2011 is referred to as historical
p.(None): data. It may be incomplete or contain inconsistencies. For instance, the end date of a trial may not have been entered,
p.(None): so the trial may appear to have a trial status of ‘Ongoing’ when in fact it has been completed. Member states
p.(None): implemented the Directive and started using EudraCT at different times between 2004 and 2006 and the links with the
p.(None): ethics committees needed to be established. The validation rules applying to the data have been upgraded and the EMA is
p.(None): working with national competent authorities to ensure key data on the status of existing trials is complete
p.(None): Q.8 Where can I get more information about a specific trial?
...
General/Other / Relationship to Authority
Searching for indicator authority:
(return to top)
p.(None): • The description of any paediatric clinical trial with investigator sites in the European Union.
p.(None): • The description of any paediatric clinical trial that is marketing authorisation holder- sponsored and involves
p.(None): the use in the paediatric population of a medicinal product covered by an EU marketing authorisation (Article 46 of
p.(None): Regulation (EC) No 1901/2006), including those where the investigator sites are outside the European Union.
p.(None):
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 2/7
p.(None):
p.(None): • The description of any trials which form part of an agreed paediatric investigation plan (PIP) including those
p.(None): where the investigator sites are outside the European Union.
p.(None): • Summaries of results of the clinical trials mentioned above (if results have been posted by the sponsor or
p.(None): marketing authorisation holder).
p.(None): • Summaries of results (with a reduced set of data fields) of paediatric trials that were completed by 26 January
p.(None): 2007 in respect of products covered by an EU marketing authorisation (Article 45 of Regulation (EC) No 1901/2006)
p.(None): [These trials are presented in a dedicated tab in the user interface.]
p.(None): The EU Clinical Trials Register website does not:
p.(None):
p.(None): • Provide information on non-interventional clinical trials of medicines (observational studies on authorised
p.(None): medicines).
p.(None): • Provide access to the authorisation document from the national medicine regulatory authority or the opinion
p.(None): document from the relevant ethics committee.
p.(None): • Provide information on clinical trials for surgical procedures, medical devices or psychotherapeutic procedures.
p.(None): • Manage the process for joining any clinical trial published on the website.
p.(None):
p.(None): • Provide navigation and web content in languages other than English.
p.(None): *Information on non-interventional post authorisation safety studies can be found on the electronic ENCePP register of
p.(None): studies which provides a publicly accessible resource for the registration of pharmacoepidemiological and
p.(None): pharmacovigilance studies.
p.(None): http://www.encepp.eu/encepp/studiesDatabase.jsp
p.(None):
p.(None): Q.4. What information is available?
p.(None): A. Information on the design of each clinical trial, its sponsor(s), the investigational medicinal product(s) and
p.(None): therapeutic area(s) involved and its trial status (authorised, ongoing, complete, etc.) is available. Users can search
p.(None): all available data using the free text search and the advanced search filters..
p.(None): • Clinical trials in the register are those which have been authorised by the national medicine regulatory
p.(None): authority and have a positive opinion of the ethics committee for clinical trials in the Member State where they have
p.(None): been run. Additionally, clinical trials including the paediatric population that have received a negative ethics
p.(None): committee opinion are also made public.
p.(None): • Phase 1 clinical trials in adults are not being made public unless they form part of an agreed Paediatric
p.(None): Investigation Plan (PIP). These criteria are those established by the guidelines published by the European Commission.
p.(None): Q.5. How do I find the EU Clinical Trials Register?
p.(None): A. The EU Clinical Trials Register is part of EudraPharm and can be accessed from the EudraPharm homepage
p.(None): The homepage of the EU Clinical Trial Register is: http://www.clinicaltrialsregister.eu
p.(None):
p.(None):
p.(None):
p.(None): EU Clinical Trials Register – FAQs
p.(None): EMA/199793/2011
p.(None): Page 3/7
p.(None):
p.(None): Q.6. Who provides the information?
p.(None): A. Protocol information on any clinical trial conducted in the EU Member States is provided, in electronic format, to
p.(None): the national medicine regulatory authorities by the trial sponsor as part of the sponsor’s application for
p.(None): authorisation to conduct a trial. It is entered into the database by the national competent authority which adds the
p.(None): authorisation, the ethics committee opinion, and later completes the end-of-trial information.
p.(None): The information on third-country clinical trials is supplied by the third country data providers (i.e.
p.(None): Paediatric-Investigation-Plan (PIP) addressees or Article 46 data providers) who enter the information directly to the
p.(None): system.
p.(None): Result related information is entered by sponsors, marketing authorisation holders and PIP addressees directly to the
p.(None): system.
p.(None): Q.7 Data displayed for some clinical trials is incomplete. How will data quality improve?
p.(None): A. National competent authorities and the Agency are working to develop, where possible, a more complete data set for
p.(None): historical trials (May 2004-March 2011) entered in the EudraCT database. Furthermore, it aims to improve the quality of
p.(None): the new records through enhanced automated checking, quality control and through the increased use of standardised
p.(None): data.
p.(None): Data quality and historical information:
p.(None):
p.(None): Information on clinical trials entered into the database between May 2004 and March 2011 is referred to as historical
p.(None): data. It may be incomplete or contain inconsistencies. For instance, the end date of a trial may not have been entered,
p.(None): so the trial may appear to have a trial status of ‘Ongoing’ when in fact it has been completed. Member states
p.(None): implemented the Directive and started using EudraCT at different times between 2004 and 2006 and the links with the
p.(None): ethics committees needed to be established. The validation rules applying to the data have been upgraded and the EMA is
...
Orphaned Trigger Words
Appendix
Indicator List
| Indicator | Vulnerability |
|---|
| access | Access to Social Goods |
| access to information | Access to information |
| authority | Relationship to Authority |
| opinion | philosophical differences/differences of opinion |
| single | Marital Status |
| union | Trade Union Membership |
Indicator Peers (Indicators in Same Vulnerability)
Trigger Words
ethics
Applicable Type / Vulnerability / Indicator Overlay for this Input